Callion Pharma is pleased to announce the publication of A Randomized Trial of a Novel Chewable Multivitamin and Mineral Supplement Following Roux-en-Y Gastric Bypass, Perin J, Prokopowicz G, Furtado M, Papas K, Steele KE.
A prototype to DEKAs Bariatric has been studied in a randomized controlled clinical trial against the standard bariatric regimen at The Johns Hopkins Center for Bariatric Surgery.
“At 3 months, plasma levels of PTH were lower (p = 0.042), and levels of vitamin D (p = 0.033), thiamine (p = 0.009), and beta-carotene (p = 0.033) were higher in the investigational multivitamin arm compared to those in the standard regimen arm. Patients receiving the investigational multivitamin reported higher taste satisfaction than those receiving the standard regimen (p = 0.035).”
“The investigational multivitamin appears to be more effective than a standard multivitamin in maintaining therapeutic levels of clinically relevant vitamins and minerals, and was more palatable.”
DEKAs Bariatric is pleasant tasting chewable tablets with an orange-peach flavor that is easy to take on a regular basis. It is easy and simple for all types of bariatric surgeries to take.
Usual Dosages for Types of Surgery Patients:
GB – 1 per day
Sleeve – 1 or 2 per day
RYGB/DS – 2 per day
About Callion Pharma
Callion Pharma is a privately held company that develops and markets advanced nutritional products that maximize the delivery of micronutrients for enhanced absorption. The Callion Pharma team combines expertise in the design, development and commercialization of disease specific products based on science and clinical evidence.
Contact us at firstname.lastname@example.org or 423-930-9243, or visit our website https://callionpharma.com.